Docetaxel compared with sequential methotrexate and 5-fluorouracil in patients with advanced breast cancer after anthracycline failure: a randomised phase III study with crossover on progression by the Scandinavian Breast Group - a nonrandomized pilo

Author： Sjostrom J.   Blomqvist C.   Mouridsen H.   Pluzanska A.   Ottosson-Lonn S.   Bengtsson N.-O.   Ostenstad B.   Mjaaland I.   Palm-Sjovall M.   Wist E.   Valvere V.   Anderson H.   Bergh J.  

Publisher： Elsevier

ISSN： 0959-8049

Source： European Journal of Cancer, Vol.35, Iss.8, 1999-08, pp. : 1194-1201

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Quality of life in patients with metastatic breast cancer receiving either docetaxel or sequential methotrexate and 5-fluorouracil. A multicentre randomised phase III trial by the Scandinavian Breast Group

By Hakamies-Blomqvist L.   Luoma M.-L.   Sjostrom J.   Pluzanska A.   Sjodin M.   Mouridsen H.   Ostenstad B.   Mjaaland I.   Ottosson-Lonn S.   Bergh J.   Malmstrom P.-O.   Blomqvist C.  

European Journal of Cancer, Vol. 36, Iss. 11, 2000-07 ,pp. : 1411-1417

Elsevier

Access to resources Recommend Favorite

C-erbB-2 expression does not predict response to docetaxel or sequential methotrexate and 5-fluorouracil in advanced breast cancer

By Sjostrom J.   Collan J.   von Boguslawski K.   Franssila K.   Bengtsson N.-O.   Mjaaland I.   Malmstrom P.   Ostenstad B.   Wist E.   Valvere V.   Bergh J.   Skiold-Petterson D.   Saksela E.   Blomqvist C.  

European Journal of Cancer, Vol. 38, Iss. 4, 2002-03 ,pp. : 535-542

Elsevier

Access to resources Recommend Favorite

Docetaxel in combination with 5-fluorouracil in patients with metastatic breast cancer previously treated with anthracycline-based chemotherapy - a phase I, dose-finding study

By Lortholary A.   Maillard P.   Delva R.   Boisdron-Celle M.   Perard D.   Vernillet L.   Besenval M.   Gamelin E.  

European Journal of Cancer, Vol. 36, Iss. 14, 2000-09 ,pp. : 1773-1780

Elsevier

Access to resources Recommend Favorite

Doxorubicin versus methotrexate both combined with cyclophosphamide, 5-fluorouracil and tamoxifen in postmenopausal patients with advanced breast cancer-a randomised study with more than 10 years follow-up from the danish breast cancer cooperative gr

By Andersson M.   Lindegaard Madsen E.   Overgaard M.   Rose C.   Dombernowsky P.   Mouridsen H.T.  

European Journal of Cancer, Vol. 35, Iss. 1, 1999-01 ,pp. : 39-46

Elsevier

Access to resources Recommend Favorite

A Randomised Phase III Cross-over Study of Tamoxifen Versus Megestrol Acetate in Advanced and Recurrent Breast Cancer

By Stuart N.S.A.   Warwick J.   Blackledge G.R.P.   Spooner D.   Keen C.   Taylor A.R.   Tyrell C.   Webster D.J.T.   Earl H.  

European Journal of Cancer, Vol. 32, Iss. 11, 1996-10 ,pp. : 1888-1892

Elsevier

Access to resources Recommend Favorite